Magnesium implantation as a continuous hydrogen production generator for the treatment of myocardial infarction in rats.
Bin Wang, Shuang Pan, Chaoqun Nie, Rentong Zou, Jiaren Liu, Xue Han, Li Dong, Jiawen Zhang, Xinrui Yang, Mengshu Yu, Bowei Fan, Xiaojian Hong, Wei Yang · Scientific reports · 2024
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In rats, the hydrogen concentration in the heart, liver, and spleen showed an increasing trend over time, and all exhibited a significant increase in hydrogen concentration at 5 and 7 days. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how inhaled hydrogen gas affected the outcomes measured in rats. The hydrogen concentration in the heart, liver, and spleen showed an increasing trend over time, and all exhibited a significant increase in hydrogen concentration at 5 and 7 days.
What the Researchers Studied
The researchers studied rats. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Source-reported hydrogen concentration: 4% source-reported H₂ gas concentration; Source-reported hydrogen exposure: 4% source-reported H₂ gas concentration; reported treatment duration: 30 min. The hydrogen concentration in the heart, liver, and spleen showed an increasing trend over time, and all exhibited a significant increase in hydrogen concentration at 5 and 7 days. The authors concluded that in summary, the researchers used a rat model of MI to evaluate the therapeutic effect of magnesium implantation for hydrogen generation compared with hydrogen inhalation. Positive staining for 8-OHdG was weaker in cardiomyocytes from the MI + hydrogen group and the MI + magnesium group, suggesting that oxidative stress was alleviated to some extent with hydrogen inhalation and magnesium slice implantation.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was rats. The study used a preclinical animal experiment. The hydrogen delivery method was inhaled hydrogen gas. The source-reported hydrogen concentration was 4% source-reported H₂ gas concentration. The reported treatment duration was 30 min.
Limitations and Safety
Reported limitations: Magnesium implantation overcomes some of the limitations of hydrogen inhalation in terms of the concentration of hydrogen that can be achieved in the target organs and the duration of exposure.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.